<?xml version="1.0" encoding="UTF-8"?>
<p id="p0175">In December 2019, a novel coronavirus named SARS-CoV2 was identified in Wuhan, China; it causes the coronavirus disease (COVID-19), which in a minority of people progresses to severe atypical pneumonia that requires hospitalization and has extremely high mortality among the elderly and immunocompromised people.
 <xref rid="bb0290" ref-type="bibr">
  <sup>57</sup>
 </xref> SARS-CoV-2, being highly contagious, caused a pandemic (COVID-19) in the early months of 2020. SARS-CoV and SARS-CoV-2 share 86% genome homology: they both infect humans by entering the lower respiratory tract through the angiotensin-converting enzyme 2 (ACE2).
 <xref rid="bb0295" ref-type="bibr">
  <sup>58</sup>
 </xref> However, an amino acid composition difference of about 25% was found between the SUD of the two viruses,
 <xref rid="bb0300" ref-type="bibr">
  <sup>59</sup>
 </xref> therefore further characterization of the SARS-CoV-2 SUD will be necessary to assess its function and possible interaction with G4 nucleic acids.
</p>
